The Way to Clinical Application of Human Pluripotent Stem Cells




8.

Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One. 2012;7(12), e52787. doi:10.​1371/​journal.​pone.​0052787. Epub 2012 Dec 27.PubMedCentralCrossRefPubMed


9.

Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. 2014;14(4):535–48. doi:10.​1016/​j.​stem.​2014.​01.CrossRefPubMed


10.

Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T, et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation. 2012;126(11 Suppl 1):S29–37.CrossRefPubMed


11.

Hemmi N, Tohyama S, Nakajima K, Kanazawa H, Suzuki T, Hattori F, et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Stem Cells Transl Med. 2014;3(12):1473–83. doi:10.​5966/​sctm.​2014-0072. Epub 2014 Oct 29.CrossRefPubMed

Oct 6, 2016 | Posted by in GASTROENTEROLOGY | Comments Off on The Way to Clinical Application of Human Pluripotent Stem Cells

Full access? Get Clinical Tree

Get Clinical Tree app for offline access